Propranolol Hydrochloride

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma

Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

Beta-blocker Administration for Cardiomyocyte Division

Propranolol Treatment for Postoperative Chylothorax

Reconsolidation Therapy With Propranolol as a Treatment for Chronic Pain

Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms

Propranolol for the Treatment of Kaposi Sarcoma in Adults

PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)

Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma

Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer

Sex Differences in Sympathetic Vascular Reactivity at High Altitude

Propranolol Rescue of Prolonged Labor

Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation

Perioperative Propranolol in Patients With Post Traumatic Stress Disorder (PTSD)

Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators